FMC (FMC) CEO Pierre Brondeau receives 271,948-share stock award

Rhea-AI Filing Summary

FMC Corp reported that Chairman, CEO and President Pierre R. Brondeau acquired 271,948 shares of Common Stock as a grant, award, or other acquisition on February 19, 2026. The transaction was recorded at a price of $0.00 per share, reflecting a stock-based award rather than an open-market purchase. Following this award, Brondeau directly owns 572,854 shares of FMC common stock.

Insights

Equity Compensation Analyst

Large stock award increases CEO’s direct equity stake.

The filing shows FMC Corp’s Chairman, CEO and President, Pierre R. Brondeau, received a stock-based award of 271,948 common shares at $0.00 per share on February 19, 2026. This is classified as a grant or award, not a market purchase.

After this transaction, his direct holdings rise to 572,854 shares. Such awards typically align executive incentives with shareholders by linking leadership wealth to share performance, though the filing does not provide details on vesting, performance conditions, or any underlying incentive plan terms.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRONDEAU PIERRE R

(Last) (First) (Middle)

FMC CORPORATION

2929 WALNUT STREET

(Street)

PHILADELPHIA PA 19104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FMC CORP [ FMC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		A		271,948	A	$0	572,854	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Sara Ponessa, as attorney in fact for Pierre R. Brondeau	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did FMC (FMC) CEO Pierre Brondeau report in this Form 4?

Pierre R. Brondeau reported receiving a grant or award of 271,948 FMC common shares on February 19, 2026. The shares were recorded at $0.00 per share, indicating stock-based compensation rather than an open-market transaction.

How many FMC (FMC) shares does Pierre Brondeau own after this award?

After the reported grant, Pierre R. Brondeau directly owns 572,854 shares of FMC common stock. This total reflects his holdings immediately following the 271,948-share award reported in the Form 4 and shows his increased equity stake in the company.

Was the FMC (FMC) insider transaction a stock purchase or a grant?

The transaction was a grant, award, or other acquisition, not an open-market purchase. It is coded as an “A” transaction in the Form 4 and lists a $0.00 per-share price, consistent with stock-based compensation granted by the company.

What type of security did FMC (FMC) report in this insider filing?

The filing involves Common Stock of FMC Corp. Pierre R. Brondeau received 271,948 common shares as an equity award, increasing his directly owned common stock position to a total of 572,854 shares following the transaction.

Does the FMC (FMC) Form 4 show any insider stock sales?

The Form 4 does not report any sales. It shows one acquisition transaction coded as a grant or award of 271,948 common shares, with no corresponding disposition of shares disclosed in this particular insider filing.